COMP <GO>
TWST vs UNH // EV/EBITDA & P/E VALUATION
Twist Bioscience Corporation (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TWST 4
— UNH 9
■ METRIC PARITY
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
valuation
—
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TWST VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TWST | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 94.20% | 88.57% | +5.63 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | 11.47% | -23.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.66% | 6.48% | -7.14 | UNH | /fcf-yield <GO> |
| Operating Margin | -4.20% | 4.82% | -9.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 3.14% | -5.54 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 6.46% | +10.04 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.12 | +22.88 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 59.2 | -2.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.33 | +0.65 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 17.7x | +3.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.50B | $368.83B | -$357.33B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TWST REV | UNH REV | TWST GROSS % | UNH GROSS % | TWST FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $447.57B | — | 88.7% | -$75.6M | $16.07B |
| FY 2024 | $0 | $400.28B | — | 88.3% | -$69.2M | $20.70B |
| FY 2023 | $0 | $371.62B | — | 89.6% | -$142.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TWST // BETA 0.98
UNH // BETA 0.33